MedTrace Logo

Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)

NCT03343158 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2260

Last updated 2021-02-05

No results posted yet for this study

Summary

Investigators propose to assess the sensitivity, specificity, positive and negative predictive value of an HIV Risk Screening Tool in identifying the risk of being HIV-infected among Orphans and Vulnerable Children (OVC) aged 2-18 years in a community setting.

Conditions

  • Orphans, Children, Adolescents
  • Vulnerable Children, Adolescents
  • Community-based

Sponsors & Collaborators

  • JSI Research & Training Institute, Inc.

    collaborator OTHER

  • Biomedical Research and Training Institute, Zimbabwe

    collaborator OTHER

  • United States Agency for International Development (USAID)

    collaborator FED

  • World Education, Inc.

    collaborator INDUSTRY

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • Agnes Mahomva, MD · Elizabeth Glaser Pediatric AIDS Foundation

  • Godfrey Woelk, PhD · Elizabeth Glaser Pediatric AIDS Foundation

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-17
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03343158 on ClinicalTrials.gov